The US Supreme Court let stand a $194 million award against Eli Lilly & Co. in a whistleblower suit accusing the company of engaging in Medicaid fraud by misreporting its drug prices.
Latest posts by Toimitus (see all)
Funding cuts in health research, and the antivaccine movement make it challenging to respond to …